Follow
MARTA MARTÍN IZQUIERDO
MARTA MARTÍN IZQUIERDO
Unknown affiliation
Verified email at usal.es
Title
Cited by
Cited by
Year
Molecular diagnosis of inherited coagulation and bleeding disorders
JM Bastida, R Benito, ML Lozano, A Marín-Quilez, K Janusz, ...
Seminars in thrombosis and hemostasis 45 (07), 695-707, 2019
382019
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
C Pérez‐Carretero, M Hernández‐Sánchez, T González, ...
International Journal of Cancer 147 (10), 2780-2792, 2020
292020
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del (11q) CLL cells to dual BCR and PARP inhibition
M Quijada-Álamo, M Hernández-Sánchez, V Alonso-Pérez, ...
Leukemia 34 (6), 1599-1612, 2020
292020
Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency
I García-Tuñón, V Alonso-Pérez, E Vuelta, S Pérez-Ramos, M Herrero, ...
PloS one 14 (5), e0216674, 2019
292019
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia
M Martín-Izquierdo, M Abáigar, JM Hernández-Sánchez, D Tamborero, ...
Haematologica 106 (8), 2215, 2021
182021
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
M Quijada-Álamo, M Hernández-Sánchez, AE Rodríguez-Vicente, ...
Blood Cancer Journal 11 (7), 127, 2021
152021
Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing
JM Bastida, S Morais, V Palma-Barqueros, R Benito, N Bermejo, ...
Annals of medicine 51 (2), 141-148, 2019
142019
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
K Janusz, MM Izquierdo, FL Cadenas, F Ramos, JMH Sánchez, ...
Annals of hematology, 1-10, 2021
112021
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
M Quijada‐Álamo, C Pérez‐Carretero, M Hernández‐Sánchez, ...
Clinical and Translational Medicine 11 (2), e304, 2021
112021
DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
M Hernández-Sánchez, AE Rodríguez-Vicente, IGG y Marín, ...
Experimental Hematology 72, 9-13, 2019
102019
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
D Quwaider, LA Corchete, M Martín-Izquierdo, JM Hernández-Sánchez, ...
Experimental Hematology & Oncology 11 (1), 18, 2022
72022
Integrated genomic analysis of chromosomal alterations and mutations in B-cell acute lymphoblastic leukemia reveals distinct genetic profiles at relapse
M Forero-Castro, A Montaño, C Robledo, A García de Coca, JL Fuster, ...
Diagnostics 10 (7), 455, 2020
72020
Solar-heated absorption system: experimental results for summer period 1984
M Izquierdo, D Tinaut
Ponencian, Poster and Proceedings of the XXIII Renc Int COMPLES: la Energıa …, 1985
61985
TRAF3 alterations are frequent in del‐3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
C Pérez‐Carretero, M Hernández‐Sánchez, T González, ...
American Journal of Hematology 97 (7), 903-914, 2022
42022
Indeterminate dendritic cell tumor as cutaneous involvement of chronic myelomonocytic leukemia successfully treated with phototherapy
A Santos-Briz, M Medina-Miguelañez, D Moyano-Bueno, ...
The American Journal of Dermatopathology 42 (11), 876-880, 2020
42020
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
N Vega-Garcia, R Benito, E Esperanza-Cebollada, M Llop, C Robledo, ...
Journal of Personalized Medicine 10 (4), 244, 2020
32020
Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and …
L Hurtado-Navarro, EJ Cuenca, E Soler, A Jerez, H Martínez-Banaclocha, ...
Blood 138, 3670, 2021
12021
Biological Impact of Monoallelic and Biallelic BIRC3 Loss in Del (11q) Chronic Lymphocytic Leukemia Progression
MQ Álamo, M Hernandez-Sanchez, AE Rodriguez, CP Carretero, ...
Blood 136, 4, 2020
12020
Clinical and Biological Impact of TP53 Alterations in Del (11q) Chronic Lymphocytic Leukemia
CP Carretero, MQ Álamo, M Hernandez-Sanchez, AE Rodriguez, ...
Blood 136, 6-7, 2020
12020
Experimental plant of solar energy thermal applications 1985
D Tinaut, M Izquierdo, F Ramos, E Tasdemiroglou, A Calera, ...
Int. Congress of Renewable Energy Sources, Madrid 2, 1254-1263, 1986
11986
The system can't perform the operation now. Try again later.
Articles 1–20